To date, we have paid attention to interleukin (IL)-6 and tumor necrosis factor (TNF)-α in patients with IBD; however, they are not always specific biomarkers for IBD (Cioffi et al., 2015; Norouzinia et al., 2017). This evidence concerns the gene IL6 and inflammatory bowel disease.